Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001573889 | SCV002563293 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | PKD1: BP4, BP5 |
Department of Pathology and Laboratory Medicine, |
RCV005395084 | SCV006052529 | uncertain significance | Polycystic kidney disease, adult type | 2024-10-17 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573889 | SCV001800399 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001573889 | SCV001954839 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003948617 | SCV004768834 | uncertain significance | PKD1-related disorder | 2023-12-21 | no assertion criteria provided | clinical testing | The PKD1 c.3548C>T variant is predicted to result in the amino acid substitution p.Ser1183Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of South Asian descent in gnomAD. Although we suspect this variant could be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |